Effects of glucocorticoids on activation of c-jun N-terminal, extracellular signal-regulated, and p38 MAP kinases in human pulmonary endothelial cells

Biochemical Pharmacology

Volumn 62, Issue 12, 2001, Pages 1719-1724

  Pelaia, Girolamo ^a,c   Cuda, Giovanni ^a   Vatrella, Alessandro ^b   Grembiale, Rosa Daniela ^a   De Sarro, Giovanbattista ^a   Maselli, Rosario ^a   Costanzo, Francesco Saverio ^a   Avvedimento, Vittorio Enrico ^a   Rotiroti, Domenicantonio ^a   Marsico, Serafino Antonio ^b  

^a UNIVERSITY MAGNA GRAECIA OF CATANZARO   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c Faculty of Medicine   (Italy)

Author keywords

GCS; H2O2; IL 1 ; MAPK; TNF

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID; HYDROGEN PEROXIDE; INTERLEUKIN 1BETA; ISOENZYME; MITOGEN ACTIVATED PROTEIN KINASE; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL STIMULATION; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LUNG; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

CELLS, CULTURED; DEXAMETHASONE; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; GLUCOCORTICOIDS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LUNG; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; MITOGEN-ACTIVATED PROTEIN KINASES; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION;

EID: 0035894293     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(01)00791-2     Document Type: Article

References (41)

1. Transcriptional regulation by steroid hormones
2. Molecular mechanisms of corticosteroid actions
3. Physical association and functional antagonism between the p65 subunit of transcription factor NF-kappa B and the glucocorticoid receptor
4. Glucocorticoid mediated repression of NF-κB activity in endothelial cells does not involve induction of IκB synthesis
5. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
6. Nuclear receptor/AP-1 interaction
7. Functional interactions between Stat5 and the glucocorticoid receptor
8. Interactions in the transcriptional regulation exerted by Stat5 and by members of the steroid hormone receptor family
9. Mechanisms of glucocorticoid-receptor-mediated repression of gene expression
10. Post-transcriptional regulation of granulocyte-macrophage colony-stimulating factor synthesis in murine T cells
11. Repression of cyclooxygenase-2 and prostaglandin E2 release by dexamethasone occurs by transcriptional and post-transcriptional mechanisms involving loss of polyadenylated mRNA
12. Mitogen-activated protein kinase: Conservation of a three-kinase module from yeast to human
13. Regulation of gene expression by reactive oxygen
14. AP-1 function, and regulation
15. Analysis of the interaction between c-Jun and c-Jun N-terminal kinase in vivo
16. Signal transduction by the c-Jun N-terminal kinase (JNK): From inflammation to development
17. ERKS: A family of protein serine/threonine kinases that are activated, and tyrosine phosphorylated in response to insulin, and NGF
18. Serine/threonine phosphorylation in cytokine signal transduction
19. Mammalian MAP kinase signalling cascades
20. New insights into the control of MAP kinase pathways
21. Endothelial cell activation: A central pathophysiological process
22. Role of transcription factors in inflammatory lung diseases
23. Mitogen-activated protein kinase cascades as regulators of stress responses
24. Gene-regulating protein kinases as important anti-inflammatory targets
25. Mitogenic signaling in androgen sensitive and insensitive prostate cancer cell lines
26. Hormone-activated nuclear receptors inhibit the stimulation of the JNK and ERK signalling pathways in endothelial cells
27. Glucocorticoid receptor down-regulates c-Jun amino terminal kinases induced by tumor necrosis factor α in fetal rat hepatocyte primary cultures
28. Jun N-terminal kinase/stress-activated protein kinase (JNK/SAPK) is required for lipopolysaccharide stimulation of tumor necrosis factor alpha (TNF-α) translation: Glucocorticoids inhibit TNF-α translation by blocking JNK/SAPK
29. Nuclear hormone receptor antagonism with AP-1 by inhibition of the JNK pathway
30. Dexamethasone destabilizes cyclooxygenase 2 mRNA by inhibiting mitogen-activated protein kinase p38
31. Long-term treatment of Swiss 3T3 fibroblasts with dexamethasone attenuates MAP kinase activation induced by insulin-like growth factor-I (IGF-I)
32. Activation of the mitogen-activated protein kinase cascade is suppressed by low concentrations of dexamethasone in mast cells
33. Glucocorticoids inhibit proliferation, cyclin D1 expression, and retinoblastoma protein phosphorylation, but not activity of the extracellular-regulated kinases in human cultured airway smooth muscle
34. Glucocorticoids antagonize AP-1 by inhibiting the activation/phosphorylation of JNK without affecting its subcellular distribution
35. Corticosteroid-resistant bronchial asthma is associated with increased c-fos expression in monocytes and T lymphocytes
36. In vivo resistance to corticosteroids in bronchial asthma is associated with enhanced phosphorylation of Jun N-terminal kinase and failure of prednisolone to inhibit Jun N-terminal kinase phosphorylation
37. Immunopharmacology: Anti-inflammatory therapy targeting transcription factors
38. The p38 MAP kinase pathway signals for cytokine-induced mRNA stabilization via MAP kinase-activated protein kinase 2 and an AU-rich region-targeted mechanism
39. The p38 mitogen-activated protein kinase is required for NF-κB-dependent gene expression
40. Eotaxin induces degranulation and chemotaxis of eosinophils through the activation of ERK2 and p38 mitogen-activated protein kinases
41. SB 239063, a potent p38 MAP kinase inhibitor, reduces inflammatory cytokine production, airways eosinophil infiltration, and persistence